Best SellerSynthetic acetylated heptapeptide fragment of Thymosin Beta-4, supplied for in vitro research applications.
Purity
99%+
CAS Number
77591-33-4
Status
In Stock
Dispatch
Same-Day (before 2pm)
Select Size
£199.99
Research verification required. All orders are reviewed before dispatch. You will receive an email confirmation and a WhatsApp or phone call within 60 minutes to verify your research purpose.
TB-500 is a synthetic acetylated heptapeptide corresponding to the active 17–23 region of the naturally occurring Thymosin Beta-4 protein. It has been investigated in preclinical research for its role in actin sequestration, cell migration, and tissue remodelling pathways. Supplied as lyophilised powder for in vitro laboratory research only.
| Compound Name | TB-500 |
| Category | Healing & Recovery |
| CAS Number | 77591-33-4 |
| Molecular Weight | 888.0 g/mol |
| Molecular Formula | C₃₈H₆₈N₉O₁₄ |
| Sequence | Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln |
| Purity | ≥99%+ (HPLC) |
| Form | Lyophilised powder |
| Storage | Store lyophilised at -20°C. Protect from light. Reconstituted: aliquot and store at -80°C. Use within 30 days of reconstitution. |
| Reconstitution | Reconstitute in bacteriostatic water or sterile 0.9% saline. Typical stock concentration: 2 mg/mL. |
Every order of TB-500 includes a batch-specific CoA with HPLC chromatogram, mass spectrometry data, and laboratory accreditation details.
A synthetic acetylated heptapeptide fragment of Thymosin Beta-4 investigated in preclinical research for its role in actin binding and tissue remodelling.
99%+, confirmed by independent third-party HPLC analysis. Batch-specific CoA included.
No. Supplied for in vitro laboratory research only. Not a licensed medicine.
TB-500 is supplied by Premio Peptides (BELL RED LIMITED) exclusively for in vitro laboratory research. It is not a licensed medicine, is not approved for human or veterinary use, and must not be administered to any living organism outside a formally approved research protocol. Purchasers assume full responsibility for compliance with applicable regulations.